Retatrutide provides metabolic regulation through GLP-1, GIP, and glucagon receptor activation
The clinical evidence base for semaglutide in weight management is substantial
Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic amp
Dietary changes may alter medication metabolism, necessitating close collaboration between psychiatrists, dietitians, and primary care clinicians
21 Radioligand-binding studies have shown high densities of GLP-1 receptors in the lateral septum, the subfornical organ, the thalamus, the hypothalamus, the interpenduncular nucleus, the posterodorsal tegmental nucleus, the area postrema (AP), the inferior olive and the nucleus tractus solitarius (NTS)
Evaluate how each site handles updates, seasonal events, and loyalty pathways, and note whether improvements are communicated clearly